FDA gives expedited approval to new groundbreaking pancreatic cancer drug

FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancerThe US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of the disease.FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumor growth in more than 90% of pancreat

You might also like

Politics

Flight attendant’s breast cancer was occupational disease, court rules

Politics

Why northern Mozambique’s surging violence is worsening displacement crisis

Politics

Deadly flash floods sweep through northern Nepal